Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) and Nrf-2-dependent genes by ischaemic pre-conditioning and post-conditioning: New adaptive endogenous protective responses against renal ischaemia/reperfusion injury

Acta Physiologica

Volumn 210, Issue 2, 2014, Pages 342-353

  Shokeir, A A ^a   Hussein, A M ^b   Barakat, N ^a   Abdelaziz, A ^b   Elgarba, M ^c   Awadalla, A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c OMAR AL MUKHTAR UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

Apoptosis; Cytokines; HO 1; Ischaemia reperfusion; NQO 1; Nrf2; Post conditioning; Pre conditioning

Indexed keywords

CASPASE 3; CREATININE; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MESSENGER RNA; OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE 1 (NAPDH); TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NFE2L2 PROTEIN, RAT; NQO1 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE EXPRESSION; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; ADAPTATION; ANIMAL; IMMUNOHISTOCHEMISTRY; METABOLISM; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ACUTE KIDNEY INJURY; ADAPTATION, PHYSIOLOGICAL; ANIMALS; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MALE; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY;

EID: 84892438618     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12164     Document Type: Article

References (47)

1. Ambros, J.T., Herrero-Fresneda, I., Borau, O.G. & Boira, J.M. 2007. Ischemic preconditioning in solid organ transplantation: from experimental to clinics. Transpl Int 20, 219-229.
2. Amstrong, S.C. 2004. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61, 427-436.
3. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. & Freeman, B.A. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87, 1620-1624.
4. Bell, K.F., Fowler, J.H., Al-Mubarak, B., Horsburgh, K. & Hardingham, G.E. 2011. Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid Med Cell Longev 2011, 689524.
5. Bonventre, J.V. & Zuk, A. 2004. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66, 480-485.
6. Chen, H., Xing, B., Liu, X., Zhan, B., Zhou, J., Zhu, H. & Chen, Z. 2008. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transpl Int 21, 364-371.
7. Cohen, M.V., Yang, X.M. & Downey, J.M. 2006. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70, 231-239.
8. Duan, W.R., Garner, D.S., Williams, S.D., Funckes-Shippy, C.L., Spath, I.S. & Blomme, E.A. 2003. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199, 221-228.
9. Funaki, H., Shimizu, K., Harada, S., Tsuyama, H., Fushida, S., Tani, T. & Miwa, K. 2002. Essential role for nuclear factor kappa B in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation 74, 551-556.
10. Hernandez, D.J., Roberts, W.B., Miles-Thomas, J., Magheli, A., Saha, S., Schaeffer, E.M., Racusen, L.C. & Allaf, M.E. 2008. Can ischemic preconditioning ameliorate renal ischemia-reperfusion injury in a single-kidney porcine model? J Endourol 22, 2531-2536.
11. Kaushal, G.P., Singh, A.B. & Shah, S.V. 1998. Identification of gene family of caspases in rat kidney and altered expression in ischemia reperfusion injury. Am J Physiol 274(3 Pt 2), F587-F595.
12. Kensler, T.W., Wakabayashi, N. & Biswal, S. 2007. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47, 89-116.
13. Leonard, M.O., Kieran, N.E., Howell, K., Burne, M.J., Varadarajan, R., Dhakshinamoorthy, S., Porter, A.G., O'Farrelly, C., Rabb, H. & Taylor, C.T. 2006. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 20, 2624-2626.
14. Liu, M., Grigoryev, D.N., Crow, M.T., Haas, M., Yamamoto, M., Reddy, S.P. & Rabb, H. 2009. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int 76, 277-285.
15. Livak, K.J. & Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DDC (t)). Methods 25, 402-408.
16. Mc Cord, J.M. 1985. Oxygen -derived free radicals in postischemic tissue injury. N Engl J Med 312, 159-163.
17. Munshi, R., Hsu, C. & Himmelfarb, J. 2011. Advances in understanding ischemic acute kidney injury. BMC Med 9, 11.
18. Murry, C.E., Jennings, R.B. & Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
19. Ovize, M., Baxter, G.F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D.J., Heusch, G., Vinten-Johansen, J., Yellon, D.M. & Schulz, R. 2010. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87, 406-423.
20. Ruiz, S., Pergola, P.E., Zager, R.A. & Vaziri, N.D. 2013. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 83, 1029-1041.
21. Saikumar, P., Dong, Z., Patel, Y., Hall, K., Hopfer, U., Weinberg, J.M. & Venkatachalam, M.A. 1998. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 17, 3401-3415.
22. Saito, M. & Miyagawa, I. 2000. Real-time monitoring of nitric oxide in ischaemia -reperfusion injury rat kidney. Urol Res 28, 141-146.
23. Serviddio, G., Romano, A.D., Gesualdo, L., Tamborra, R., Di Palma, A.M., Rollo, T., Altomare, E. & Vendemiale, G. 2008. Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant 23, 1504-1512.
24. Shah, Z.A., Li, R.C., Thimmulappa, R.K., Kensler, T.W., Yamamoto, M., Biswal, S. & Doré, S. 2007. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience 147, 53-59.
25. Sheridan, A.M. & Bonventre, J.V. 2000. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9, 427-434.
26. Shih, A.Y., Li, P. & Murphy, T.H. 2005. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci 25, 10321-10335.
27. Shokeir, A.A., Hussein, A.M., Awadalla, A., Samy, A., Abdelaziz, A., Khater, S. & Barakat, N. 2012. Protection against renal ischemia/ reperfusion injury: a comparative experimental study of the impact of ischemic preconditioning versus postconditioning. Arab J Urol 10, 418-424.
28. Srivastava, S., Alfieri, A., Siow, R.C.M., Mann, G.E. & Fraser, P.A. 2013. Temporal and spatial distribution of Nrf2 in rat brain following stroke: quantitation of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique. J Physiol 591, 3525-3538.
29. 2 overload. Am J Physiol Heart Circ Physiol 288, H1900-H1908.
30. Tanaka, Y., Maher, J.M., Chen, C. & Klaassen, C.D. 2007. Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. Mol Pharmacol 71, 817-825.
31. Teoh, N., Dela Pena, A. & Farrell, G. 2002. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappa B, p38 kinase, and cell cycle entry. Hepatology 36, 94-102.
32. Timsit, M.O., Gadet, R., Ben Abdennebi, H., Codas, R., Petruzzo, P. & Badet, L. 2008. Renal ischemic preconditioning improves recovery of kidney function and decreases alpha-smooth muscle actin expression in a rat model. J Urol 180, 388-391.
33. Torras, J., Herrero-Fresneda, I., Lloberas, N., Riera, M., Ma Cruzado, J. & Ma Grinyó, J. 2002. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 61, 2218.
34. Tsang, A., Hausenloy, D.J., Mocanu, M.M. & Yellon, D.M. 2004. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95, 230-232.
35. Unal, S., Ozmen, S., Demiir, V., Bradford, M.M., Lobocki, C. & Silberberg, B. 2001. The effect of gradually increased blood flow on ischemia-reperfusion injury. Ann Plast Surg 47, 412-416.
36. Vinten-Johansen, J., Zhao, Z.Q., Zatta, A.J., Kin, H., Halkos, M.E. & Kerendi, F. 2005. Postconditioning: new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 100, 295-310.
37. Weight, S.C., Waller, J.R., Bradley, V., Whiting, P.H. & Nicholeson, M.L. 2001. Interaction of eicosanoids and nitric oxide in renal reperfusion injury. Transplantation 72, 614-619.
38. Wu, Q.Q., Wang, Y., Senitko, M., Meyer, C., Wigley, W.C., Ferguson, D.A., Grossman, E., Chen, J., Zhou, X.J., Hartono, J., Winterberg, P., Chen, B., Agarwal, A. & Lu, C.Y. 2011. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1. Am J Physiol Renal Physiol 300, F1180-F1192.
39. Xuan, Y.T., Guo, Y., Zhu, Y., Wang, O.L., Rokosh, G. & Bolli, R. 2007. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase-pSer-signal transducers and activators of transcription 1/3 pathway. Circulation 116, 535-544.
40. Yang, X.M., Poctor, J.B., Cui, L., Halkos, M., Kin, H., Guyton, R.A., Vinten-Johansen, J. & Zhao, Z.Q. 2004. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 44, 1103-1110.
41. Yang, C.C., Lin, L.C., Wu, M.S., Chien, C.T. & Lai, M.K. 2009. Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling. Transplantation 88, 1251-1260.
42. Yellon, D.M. & Downey, J.M. 2003. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83, 1113-1151.
43. Ysebaert, D.K., De Greef, K.E., De Beuf, A., Van Rompay, A.R., Vercauteren, S., Persy, V.P. & De Broe, M.E. 2004. T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66, 491-496.
44. Zhang, D.D. 2006. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38, 769-789.
45. Zhang, X., Xiao, Z., Yao, J., Zhao, G., Fa, X. & Niu, J. 2013. Participation of protein kinase C in the activation of Nrf2 signaling by ischemic preconditioning in the isolated rabbit heart. Mol Cell Biochem 372, 169-179.
46. Zhao, Z.Q. & Vinten-Johansen, J. 2006. Postconditioning: reduction of reperfusion-induced injury. J Cardiovasc Res 70, 200-211.
47. Zhuang, S., Lu, B. & Pang, M. 2009. Postconditioning does not improve renal function or attenuate tubular damage in ischemia/reperfusion-induced acute kidney injury in mice. Open Pathol J 3, 18-21.